51
|
Shpichka A, Osipova D, Efremov Y, Bikmulina P, Kosheleva N, Lipina M, Bezrukov EA, Sukhanov RB, Solovieva AB, Vosough M, Timashev P. Fibrin-based Bioinks: New Tricks from an Old Dog. Int J Bioprint 2020; 6:269. [PMID: 33088984 PMCID: PMC7557349 DOI: 10.18063/ijb.v6i3.269] [Citation(s) in RCA: 14] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/28/2020] [Accepted: 03/15/2020] [Indexed: 01/05/2023] Open
Abstract
For the past 10 years, the main efforts of most bioprinting research teams have focused on creating new bioink formulations, rather than inventing new printing set-up concepts. New tissue-specific bioinks with good printability, shape fidelity, and biocompatibility are based on "old" (well-known) biomaterials, particularly fibrin. While the interest in fibrin-based bioinks is constantly growing, it is essential to provide a framework of material's properties and trends. This review aims to describe the fibrin properties and application in three-dimensional bioprinting and provide a view on further development of fibrin-based bioinks.
Collapse
Affiliation(s)
- Anastasia Shpichka
- Department of Advanced Biomaterials, Institute for Regenerative Medicine, Sechenov First Moscow State Medical University, Moscow, Russia.,Department of Chemistry, Lomonosov Moscow State University, Moscow, Russia
| | - Daria Osipova
- Department of Advanced Biomaterials, Institute for Regenerative Medicine, Sechenov First Moscow State Medical University, Moscow, Russia
| | - Yuri Efremov
- Department of Advanced Biomaterials, Institute for Regenerative Medicine, Sechenov First Moscow State Medical University, Moscow, Russia
| | - Polina Bikmulina
- Department of Advanced Biomaterials, Institute for Regenerative Medicine, Sechenov First Moscow State Medical University, Moscow, Russia
| | - Nastasia Kosheleva
- Department of Molecular and Cell Pathophysiology, FSBSI Institute of General Pathology and Pathophysiology, Moscow, Russia.,Department of Embryology, Lomonosov Moscow State University, Faculty of Biology, Moscow, Russia
| | - Marina Lipina
- Department of Traumatology, Orthopedics and Disaster Surgery, Sechenov First Moscow State Medical University, Moscow, Russia
| | - Evgeny A Bezrukov
- Department of Urology, Sechenov First Moscow State Medical University, Moscow, Russia
| | - Roman B Sukhanov
- Department of Urology, Sechenov First Moscow State Medical University, Moscow, Russia
| | - Anna B Solovieva
- Department of Polymers and Composites, NN Semenov Institute of Chemical Physics, Moscow, Russia
| | - Massoud Vosough
- Department of Regenerative Medicine, Cell Science Research Centre, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran
| | - Peter Timashev
- Department of Advanced Biomaterials, Institute for Regenerative Medicine, Sechenov First Moscow State Medical University, Moscow, Russia.,Department of Chemistry, Lomonosov Moscow State University, Moscow, Russia.,Department of Polymers and Composites, NN Semenov Institute of Chemical Physics, Moscow, Russia.,Institute of Photon Technologies, Federal Research Center Crystallography and Photonics RAS, Moscow, Russia
| |
Collapse
|
52
|
Kang D, Hong G, An S, Jang I, Yun WS, Shim JH, Jin S. Bioprinting of Multiscaled Hepatic Lobules within a Highly Vascularized Construct. SMALL (WEINHEIM AN DER BERGSTRASSE, GERMANY) 2020; 16:e1905505. [PMID: 32078240 DOI: 10.1002/smll.201905505] [Citation(s) in RCA: 62] [Impact Index Per Article: 15.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/26/2019] [Revised: 01/25/2020] [Indexed: 06/10/2023]
Abstract
Highly vascularized complex liver tissue is generally divided into lobes, lobules, hepatocytes, and sinusoids, which can be viewed under different types of lens from the micro- to macro-scale. To engineer multiscaled heterogeneous tissues, a sophisticated and rapid tissue engineering approach is required, such as advanced 3D bioprinting. In this study, a preset extrusion bioprinting technique, which can create heterogeneous, multicellular, and multimaterial structures simultaneously, is utilized for creating a hepatic lobule (≈1 mm) array. The fabricated hepatic lobules include hepatic cells, endothelial cells, and a lumen. The endothelial cells surround the hepatic cells, the exterior of the lobules, the lumen, and finally, become interconnected with each other. Compared to hepatic cell/endothelial cell mixtures, the fabricated hepatic lobule shows higher albumin secretion, urea production, and albumin, MRP2, and CD31 protein levels, as well as, cytochrome P450 enzyme activity. It is found that each cell type with spatial cell patterning in bioink accelerates cellular organization, which could preserve structural integrity and improve cellular functions. In conclusion, preset extruded hepatic lobules within a highly vascularized construct are successfully constructed, enabling both micro- and macro-scale tissue fabrication, which can support the creation of large 3D tissue constructs for multiscale tissue engineering.
Collapse
Affiliation(s)
- Donggu Kang
- Research Institute, T&R Biofab. Co. Ltd., 242 Pangyo-ro, Seongnam-si, 13487, Republic of Korea
| | - Gyusik Hong
- Department of Mechanical Engineering, Korea Polytechnic University, 237 Sangidaehak-ro, Siheung-si, 15073, Republic of Korea
| | - Seongmin An
- Department of Mechanical Engineering, Korea Polytechnic University, 237 Sangidaehak-ro, Siheung-si, 15073, Republic of Korea
| | - Ilho Jang
- Research Institute, T&R Biofab. Co. Ltd., 242 Pangyo-ro, Seongnam-si, 13487, Republic of Korea
| | - Won-Soo Yun
- Department of Mechanical Engineering, Korea Polytechnic University, 237 Sangidaehak-ro, Siheung-si, 15073, Republic of Korea
| | - Jin-Hyung Shim
- Department of Mechanical Engineering, Korea Polytechnic University, 237 Sangidaehak-ro, Siheung-si, 15073, Republic of Korea
| | - Songwan Jin
- Department of Mechanical Engineering, Korea Polytechnic University, 237 Sangidaehak-ro, Siheung-si, 15073, Republic of Korea
| |
Collapse
|
53
|
Fan D, Staufer U, Accardo A. Engineered 3D Polymer and Hydrogel Microenvironments for Cell Culture Applications. Bioengineering (Basel) 2019; 6:E113. [PMID: 31847117 PMCID: PMC6955903 DOI: 10.3390/bioengineering6040113] [Citation(s) in RCA: 45] [Impact Index Per Article: 9.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/14/2019] [Revised: 11/13/2019] [Accepted: 12/06/2019] [Indexed: 12/28/2022] Open
Abstract
The realization of biomimetic microenvironments for cell biology applications such as organ-on-chip, in vitro drug screening, and tissue engineering is one of the most fascinating research areas in the field of bioengineering. The continuous evolution of additive manufacturing techniques provides the tools to engineer these architectures at different scales. Moreover, it is now possible to tailor their biomechanical and topological properties while taking inspiration from the characteristics of the extracellular matrix, the three-dimensional scaffold in which cells proliferate, migrate, and differentiate. In such context, there is therefore a continuous quest for synthetic and nature-derived composite materials that must hold biocompatible, biodegradable, bioactive features and also be compatible with the envisioned fabrication strategy. The structure of the current review is intended to provide to both micro-engineers and cell biologists a comparative overview of the characteristics, advantages, and drawbacks of the major 3D printing techniques, the most promising biomaterials candidates, and the trade-offs that must be considered in order to replicate the properties of natural microenvironments.
Collapse
Affiliation(s)
| | | | - Angelo Accardo
- Department of Precision and Microsystems Engineering, Delft University of Technology, Mekelweg 2, 2628 CD Delft, The Netherlands; (D.F.); (U.S.)
| |
Collapse
|
54
|
Digital dentistry: The new state of the art - Is it disruptive or destructive? Dent Mater 2019; 36:9-24. [PMID: 31526522 DOI: 10.1016/j.dental.2019.08.103] [Citation(s) in RCA: 91] [Impact Index Per Article: 18.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/05/2019] [Revised: 08/22/2019] [Accepted: 08/23/2019] [Indexed: 11/22/2022]
Abstract
OBJECTIVE Summarizing the new state of the art of digital dentistry, opens exploration of the type and extent of innovations and technological advances that have impacted - and improved - dentistry. The objective is to describe advances and innovations, the breadth of their impact, disruptions and advantages they produce, and opportunities created for material scientists. METHODS On-line data bases, web searches, and discussions with industry experts, clinicians, and dental researchers informed the content. Emphasis for inclusion was on most recent publications along with innovations presented at trade shows, in press releases, and discovered through discussions leading to web searches for new products. RESULTS Digital dentistry has caused disruption on many fronts, bringing new techniques, systems, and interactions that have improved dentistry. Innovation has spurred opportunities for material scientists' future research. SIGNIFICANCE With disruptions intrinsic in digital dentistry's new state of the art, patient experience has improved. More restoration options are available delivering longer lifetimes, and better esthetics. Fresh approaches are bringing greater efficiency and accuracy, capitalizing on the interest, capabilities, and skills of those involved. New ways for effective and efficient inter-professional and clinician-patient interactions have evolved. Data can be more efficiently mined for forensic and epidemiological uses. Students have fresh ways of learning. New, often unexpected, partnerships have formed bringing further disruption - and novel advantages. Yes, digital dentistry has been disruptive, but the abundance of positive outcomes argues strongly that it has not been destructive.
Collapse
|
55
|
Trenfield SJ, Awad A, Madla CM, Hatton GB, Firth J, Goyanes A, Gaisford S, Basit AW. Shaping the future: recent advances of 3D printing in drug delivery and healthcare. Expert Opin Drug Deliv 2019; 16:1081-1094. [PMID: 31478752 DOI: 10.1080/17425247.2019.1660318] [Citation(s) in RCA: 122] [Impact Index Per Article: 24.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/29/2022]
Abstract
Introduction: Three-dimensional (3D) printing is a relatively new, rapid manufacturing technology that has found promising applications in the drug delivery and medical sectors. Arguably, never before has the healthcare industry experienced such a transformative technology. This review aims to discuss the state of the art of 3D printing technology in healthcare and drug delivery. Areas covered: The current and future applications of printing technologies within drug delivery and medicine have been discussed. The latest innovations in 3D printing of customized medical devices, drug-eluting implants, and printlets (3D-printed tablets) with a tailored dose, shape, size, and release characteristics have been covered. The review also covers the state of the art of 3D printing in healthcare (covering topics such as dentistry, surgical and bioprinting of patient-specific organs), as well as the potential of recent innovations, such as 4D printing, to shape the future of drug delivery and to improve treatment pathways for patients. Expert opinion: A future perspective is provided on the potential for 3D printing in healthcare, covering strategies to overcome the major barriers to integration that are faced today.
Collapse
Affiliation(s)
| | - Atheer Awad
- UCL School of Pharmacy, University College London , London , UK
| | | | - Grace B Hatton
- UCL School of Pharmacy, University College London , London , UK
| | - Jack Firth
- Department of Biochemical Engineering, University College London, London, UK
| | - Alvaro Goyanes
- FabRx Ltd , Ashford , TN24 0RW , UK.,Departamento de Farmacología, Farmacia y Tecnología Farmacéutica, R + D Pharma Group (GI-1645), Universidade de Santiago de Compostela , Santiago de Compostela , Spain
| | - Simon Gaisford
- UCL School of Pharmacy, University College London , London , UK.,FabRx Ltd , Ashford , TN24 0RW , UK
| | - Abdul W Basit
- UCL School of Pharmacy, University College London , London , UK.,FabRx Ltd , Ashford , TN24 0RW , UK
| |
Collapse
|